Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre V Ivachtchenko

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Expert Opinion on Therapeutic Patents|July 24, 2012
5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivativesAlexandre V Ivachtchenko, Yan A Ivanenkov
Journal of Alzheimer'S Disease : JAD|May 28, 2016
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS DisordersAlexandre V Ivachtchenko, Yan Lavrovsky, Ilya Okun
Molecular Pharmaceutics|February 18, 2016
AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's DiseaseAlexandre V Ivachtchenko, Yan Lavrovsky, Yan A Ivanenkov
Expert Opinion on Therapeutic Patents|September 11, 2012
5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffoldsAlexandre V Ivachtchenko, Yan A Ivanenkov, Andrey V Skorenko
Expert Opinion on Therapeutic Patents|August 19, 2010
5-hydroxytryptamine subtype 6 receptor modulators: a patent surveyAlexandre V Ivachtchenko, Yan A Ivanenkov, Sergey E Tkachenko
Journal of Combinatorial Chemistry|November 11, 2003
Synthesis of substituted 4-oxo-2-thioxo-1,2,3,4-tetrahydroquinazolines and 4-oxo-3,4-dihydroquinazoline-2-thiolesAlexandre V Ivachtchenko, Sergiy M Kovalenko, Oleksandr G Drushlyak
International Journal of Molecular Sciences|September 14, 2024
Development and Prospects of Furin Inhibitors for Therapeutic ApplicationsAlexandre V Ivachtchenko, Alexander V Khvat, Dmitrii O Shkil
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
The Journal of Organic Chemistry|December 2, 2006
Complexity-enhancing acid-promoted rearrangement of tricyclic products of tandem Ugi 4CC/intramolecular Diels-Alder reactionAlexei Ilyin, Volodymyr Kysil, Mikhail Krasavin, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
Small-molecule modulators of Hh and Wnt signaling pathwaysAlex S Kiselyov, Sergey E Tkachenko, Konstantin V Balakin, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Expert Opinion on Therapeutic Patents|July 24, 2012
5HT(6) receptor antagonists: a patent update. Part 1. Sulfonyl derivativesAlexandre V Ivachtchenko, Yan A Ivanenkov
Journal of Alzheimer'S Disease : JAD|May 28, 2016
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS DisordersAlexandre V Ivachtchenko, Yan Lavrovsky, Ilya Okun
Molecular Pharmaceutics|February 18, 2016
AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's DiseaseAlexandre V Ivachtchenko, Yan Lavrovsky, Yan A Ivanenkov
Expert Opinion on Therapeutic Patents|September 11, 2012
5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffoldsAlexandre V Ivachtchenko, Yan A Ivanenkov, Andrey V Skorenko
Expert Opinion on Therapeutic Patents|August 19, 2010
5-hydroxytryptamine subtype 6 receptor modulators: a patent surveyAlexandre V Ivachtchenko, Yan A Ivanenkov, Sergey E Tkachenko
Journal of Combinatorial Chemistry|November 11, 2003
Synthesis of substituted 4-oxo-2-thioxo-1,2,3,4-tetrahydroquinazolines and 4-oxo-3,4-dihydroquinazoline-2-thiolesAlexandre V Ivachtchenko, Sergiy M Kovalenko, Oleksandr G Drushlyak
International Journal of Molecular Sciences|September 14, 2024
Development and Prospects of Furin Inhibitors for Therapeutic ApplicationsAlexandre V Ivachtchenko, Alexander V Khvat, Dmitrii O Shkil
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
The Journal of Organic Chemistry|December 2, 2006
Complexity-enhancing acid-promoted rearrangement of tricyclic products of tandem Ugi 4CC/intramolecular Diels-Alder reactionAlexei Ilyin, Volodymyr Kysil, Mikhail Krasavin, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
Small-molecule modulators of Hh and Wnt signaling pathwaysAlex S Kiselyov, Sergey E Tkachenko, Konstantin V Balakin, et al.
Pageof 7